Show simple item record

dc.contributor.authorDanquah, Michael
dc.contributor.authorForde, G.
dc.date.accessioned2017-01-30T11:22:07Z
dc.date.available2017-01-30T11:22:07Z
dc.date.created2016-09-12T08:36:34Z
dc.date.issued2008
dc.identifier.citationDanquah, M. and Forde, G. 2008. Development of a pilot-scale bacterial fermentation for plasmid-based biopharmaceutical production using a stoichiometric medium. Biotechnology and Bioprocess Engineering. 13 (2): pp. 158-167.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/10972
dc.identifier.doi10.1007/s12257-007-0080-2
dc.description.abstract

The recognition of the potential efficacy of plasmid DNA (pDNA) molecules as vectors in the treatment and prevention of emerging diseases has birthed the confidence to combat global pandemics. This is due to the close-to-zero safety concern associated with pDNA vectors compared to viral vectors in cell transfection and targeting. Considerable attention has been paid to the potential of pDNA vectors but comparatively less thought has been given to the practical challenges in producing large quantities to meet current rising demands. A pilot-scale fermentation scheme was developed by employing a stoichiometrically-designed growth medium whose exceptional plasmid yield performance was attested in a shake flask environment for pUC19 and pEGFP-N1 transformed into E. coliDH5a and E. coliJM109, respectively. Batch fermentation of E. coliDH5a-pUC19 employing the stoichiometric medium displayed a maximum plasmid volumetric and specific yield of 62.6 mg/L and 17.1 mg/g (mg plasmid/g dry cell weight), respectively. Fed-batch fermentation of E. coliDH5a-pUC19 on a glycerol substrate demonstrated one of the highest ever reported pilot-scale plasmid specific yield of 48.98 mg/g and a volumetric yield of 0.53 g/L. The attainment of high plasmid specific yields constitutes a decrease in plasmid manufacturing cost and enhances the effectiveness of downstream processes by reducing the proportion of intracellular impurities. The effect of step-rise temperature induction was also considered to maximize ColE1-origin plasmid replication. © KSBB.

dc.publisherKorean Society for Biotechnology and Bioengineering
dc.titleDevelopment of a pilot-scale bacterial fermentation for plasmid-based biopharmaceutical production using a stoichiometric medium
dc.typeJournal Article
dcterms.source.volume13
dcterms.source.number2
dcterms.source.startPage158
dcterms.source.endPage167
dcterms.source.issn1226-8372
dcterms.source.titleBiotechnology and Bioprocess Engineering
curtin.departmentCurtin Sarawak
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record